摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-羟基-N-(1,2,3,10-四甲氧基-9-氧代-6,7-二氢-5H-苯并[d]庚搭烯-7-基)乙酰胺 | 74515-40-5

中文名称
2-羟基-N-(1,2,3,10-四甲氧基-9-氧代-6,7-二氢-5H-苯并[d]庚搭烯-7-基)乙酰胺
中文别名
——
英文名称
N-(2-hydroxyacetyl)deacetylcolchicine
英文别名
colchifoline;2-hydroxy-N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide
2-羟基-N-(1,2,3,10-四甲氧基-9-氧代-6,7-二氢-5H-苯并[d]庚搭烯-7-基)乙酰胺化学式
CAS
74515-40-5
化学式
C22H25NO7
mdl
——
分子量
415.443
InChiKey
DIELAJDYLJKYSH-HNNXBMFYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.4
  • 重原子数:
    30
  • 可旋转键数:
    6
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.36
  • 拓扑面积:
    103
  • 氢给体数:
    2
  • 氢受体数:
    7

SDS

SDS:e2a28e2cf26935d2b1f3a03544a25199
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-羟基-N-(1,2,3,10-四甲氧基-9-氧代-6,7-二氢-5H-苯并[d]庚搭烯-7-基)乙酰胺盐酸 作用下, 反应 1.0h, 生成 (1R,7S)-7-chloro-3,3,7-trimethylbicyclo[4.1.0]hept-4-en-1-ol
    参考文献:
    名称:
    Iorio, Maria A.; Molinari, Marisa; Brossi, Arnold, Canadian Journal of Chemistry, 1981, vol. 59, p. 283 - 284
    摘要:
    DOI:
  • 作为产物:
    参考文献:
    名称:
    Liposomes as carriers for colchicine-derived prodrugs: Vascular disrupting nanomedicines with tailorable drug release kinetics
    摘要:
    Newly formed tumor vasculature has proven to be an effective target for tumor therapy. A strategy to attack this angiogenic tumor vasculature is to initiate local blood vessel congestion and consequently induce massive tumor cell necrosis. Vascular disrupting agents (VDAs) typically bind to tubulin and consequently disrupt microtubule dynamics. Colchicine and its derivatives (colchicinoids) are very potent tubulin binding compounds but have a narrow therapeutic index, which may be improved by employing a liposomal targeting strategy. However, as a result of their physicochemical properties, colchicinoids are problematic to retain in liposomes, as they are released relatively rapidly upon encapsulation. To overcome this limitation, two hydrolyzable PEGylated derivatives of colchicine were developed for encapsulation into the aqueous core of long-circulating liposomes: a moderately rapid hydrolyzing PEGylated colchicinoid containing a glycolic acid linker (prodrug I), and a slower hydrolyzing PEGylated colchicinoid with a lactic acid linker (prodrug II). Hydrolysis studies at 37 degrees C and pH 7.4 showed that prodrug I possessed relatively rapid conversion characteristics (t(1/2) = 5.4 h) whereas prodrug II hydrolyzed much slower (t(1/2) = 217 h). Upon encapsulation into liposomes, colchicine was released rapidly, whereas both PEGylated colchicine derivatives were efficiently retained and appeared to be released only after cleavage of the PEG-linker. This study therefore demonstrates that, in contrast to colchicine, these novel PEGylated colchicine-derived prodrugs are retained within the aqueous interior after encapsulation into liposomes, and that the release of the active parent can be controlled by using different biodegradable linkers. (C) 2011 Elsevier B.V. All rights reserved.
    DOI:
    10.1016/j.ejps.2011.08.027
点击查看最新优质反应信息

文献信息

  • Reaction of alcohols and amines with diacetyldihydrofluorescein (DADF): Conversion into erythrosine-derivatives on TLC-plates by ammonia and iodine vapors
    作者:Paam N. Sharma、Arnold Brossi
    DOI:10.1002/hlca.19840670136
    日期:1984.2.1
    Reaction of decetylcolchicine (2) and colchifoline (3) with diacetyldihydrofluorescein (1, DADF) afforded the corresponding amide and ester derivatives, converted on TLC-plates after exposure to ammonia and iodine vapors into red colored pigments. This reaction, also observed with DADF-derivatives of codeine, quinine and mescaline is highly sensitive. The red pigment produced from the DADF-ester (6)
    癸基秋水仙碱(2)和秋水仙碱(3)与二乙酰基二氢荧光素(1,DADF)反应,得到相应的酰胺和酯衍生物,在氨和碘蒸气暴露于TLC板上后转化为红色颜料。用可待因,奎宁和甲斯卡林的DADF衍生物也观察到该反应高度敏感。由氨-碘处理形成的秋水仙碱的DADF-酯(6)产生的红色颜料是相应的赤藓红酸酯衍生物。从这些研究中得出的DADF可以用作检测粗混合物中的醇和胺以及进行染料标记的有用试剂。
  • Biological effects of modified colchicines. 2. Evaluation of catecholic colchicines, colchifolines, colchicide, and novel N-acyl- and N-aroyldeacetylcolchicines
    作者:Arnold Brossi、Padam N. Sharma、Louise Atwell、Arthur E. Jacobson、Maria A. Iorio、Marisa Molinari、Colin F. Chignell
    DOI:10.1021/jm00364a006
    日期:1983.10
    A series of natural and synthetic colchicine derivatives was examined for their potency in the lymphocytic leukemia P388 screen in mice, for their toxicity in mice, and for their binding to microtubule protein. The natural alkaloids cornigerine and colchifoline and several N,O-substituted analogues of colchifoline were found to be as potent and as toxic as colchicine in the P388 screen with good affinity for tubulin. The 1,2-(methylenedioxy)-substituted isomer of cornigerine was considerably less potent in vivo than could have been anticipated from the in vitro tubulin binding data. Several N-acyl and N-aroyl derivatives prepared from deacetylcolchicine showed high potency in the in vitro and in vivo screens. Colchicide was found to be highly potent in vivo, and N-carbethoxydeacetylcolchicine, a synthetic analogue of colchicine with a N-carbethoxy instead of an N-acetyl function, showed interesting biological properties.
  • Synthesis and binding to tubulin of colchicine spin probes
    作者:Padam N. Sharma、Arnold Brossi、J. V. Silverton、Colin F. Chignell
    DOI:10.1021/jm00378a035
    日期:1984.12
    Spin probes of deacetylcholchicine (1), 4-(hydroxymethyl)colchicine (2), and colchifoline (3) have been synthesized to study the binding site for colchicine on tubulin. Acylation of 1-3 with (+/-)-2,2,5,5-tetramethyl-1-pyrrolidinyloxy-3-carboxylic acid (4) afforded diastereomeric mixtures of the esters 5-8 and the amides 9 and 10. Pure diastereomers of 3 were synthesized with 4a and 4b, which inhibited the binding of colchicine by 60%. In the presence of calf brain microtubular protein, the colchifoline spin labels underwent reduction of the nitroxide group, which precluded their use to study the topography of the colchicine binding site.
  • Liposomes as carriers for colchicine-derived prodrugs: Vascular disrupting nanomedicines with tailorable drug release kinetics
    作者:Bart J. Crielaard、Steffen van der Wal、Huong Thu Le、Aloïs T.L. Bode、Twan Lammers、Wim E. Hennink、Raymond M. Schiffelers、Marcel H.A.M. Fens、Gert Storm
    DOI:10.1016/j.ejps.2011.08.027
    日期:2012.3
    Newly formed tumor vasculature has proven to be an effective target for tumor therapy. A strategy to attack this angiogenic tumor vasculature is to initiate local blood vessel congestion and consequently induce massive tumor cell necrosis. Vascular disrupting agents (VDAs) typically bind to tubulin and consequently disrupt microtubule dynamics. Colchicine and its derivatives (colchicinoids) are very potent tubulin binding compounds but have a narrow therapeutic index, which may be improved by employing a liposomal targeting strategy. However, as a result of their physicochemical properties, colchicinoids are problematic to retain in liposomes, as they are released relatively rapidly upon encapsulation. To overcome this limitation, two hydrolyzable PEGylated derivatives of colchicine were developed for encapsulation into the aqueous core of long-circulating liposomes: a moderately rapid hydrolyzing PEGylated colchicinoid containing a glycolic acid linker (prodrug I), and a slower hydrolyzing PEGylated colchicinoid with a lactic acid linker (prodrug II). Hydrolysis studies at 37 degrees C and pH 7.4 showed that prodrug I possessed relatively rapid conversion characteristics (t(1/2) = 5.4 h) whereas prodrug II hydrolyzed much slower (t(1/2) = 217 h). Upon encapsulation into liposomes, colchicine was released rapidly, whereas both PEGylated colchicine derivatives were efficiently retained and appeared to be released only after cleavage of the PEG-linker. This study therefore demonstrates that, in contrast to colchicine, these novel PEGylated colchicine-derived prodrugs are retained within the aqueous interior after encapsulation into liposomes, and that the release of the active parent can be controlled by using different biodegradable linkers. (C) 2011 Elsevier B.V. All rights reserved.
  • Iorio, Maria A.; Molinari, Marisa; Brossi, Arnold, Canadian Journal of Chemistry, 1981, vol. 59, p. 283 - 284
    作者:Iorio, Maria A.、Molinari, Marisa、Brossi, Arnold
    DOI:——
    日期:——
查看更多

同类化合物

脱羰秋水仙碱 红陪酚四甲基醚 红倍酚 秋水仙碱甲硫代磺酸盐 秋水仙碱 硫代秋水仙碱 甲基丙烯酸7-氧代-4-(苯基偶氮)-1,3,5-环庚三烯-1-基酯 甲基6-肼基-7-氧代-1,3,5-环庚三烯-1-羧酸酯 环庚三烯酮 环庚三烯酚酮 氨甲酸,(1-乙基戊基)-,甲基酯(9CI) 桧木醇 异秋水仙胺 尼楚酮 对二硫辛酸 双环[4.4.1]十一碳-1(10),2,4,6,8-五烯-11-酮 双环[4.1.0]庚-1,3,5-三烯-7-酮 去乙酰氨基秋水仙碱 原秋水仙碱 十四烷酸,4-(十八烷氧基)-7-羰基-1,3,5-环庚三烯-1-基酯 乙基[(7S)-1,2,3,10-四甲氧基-9-氧代-5,6,7,9-四氢苯并[a]庚搭烯-7-基]氨基甲酸酯 三甲基秋水仙素酸 三甲基秋水仙素酸 三(2-羟基-2,4,6-环庚三烯-1-酮)-铟 α-(异丙基)-&#x3B3,&#x3B3-二甲基环己丙醇 beta-斧松素 [(7S)-7-乙酰氨基-1,3-二甲氧基-10-甲硫基-9-氧代-6,7-二氢-5H-苯并[d]庚搭烯-2-基]2-氯乙酸酯 [(7S)-7-乙酰氨基-1,2-二甲氧基-10-甲硫基-9-氧代-6,7-二氢-5H-苯并[d]庚搭烯-3-基]2-氯乙酸酯 N-(2-巯基乙基)秋水仙胺 N-脱乙酰基3-去甲基硫代秋水仙碱 N-脱乙酰基,1,2,3,10-脱甲基秋水仙碱 N-甲酰脱乙酰秋水仙碱 N-甲酰基秋水仙胺 N-甲基-秋水仙碱 N-三氟乙酰基-N-甲基-去乙酰基秋水仙碱 N-[(S)-5,6,7,9-四氢-1,2,3,10-四甲氧基-9-氧代苯并[a]庚搭烯-7-基]-2,2,2-三氟乙酰胺 N-[(7S)-4-(羟基甲基)-1,2,3,10-四甲氧基-9-氧代-6,7-二氢-5H-苯并[d]庚搭烯-7-基]乙酰胺 N-[(7S)-10-(丁基氨基)-5,6,7,9-四氢-1,2,3-三甲氧基-9-氧代苯并[a]庚搭烯-7-基]-乙酰胺 N-[(7S)-1,2,3-三甲氧基-9-氧代-10-(苯基甲硫基)-6,7-二氢-5H-苯并[d]庚搭烯-7-基]乙酰胺 N-[(7S)-1,2,3-三甲氧基-9-氧代-10-(苯基甲基氨基)-6,7-二氢-5H-苯并[d]庚搭烯-7-基]乙酰胺 N-[(7S)-1,2,3,10-四甲氧基-9-氧代-5,6,7,9-四氢苯并[a]庚搭烯-7-基]丙酰胺 N-[(7R)-1,2,3,10-四甲氧基-9-氧代-6,7-二氢-5H-苯并[d]庚搭烯-7-基]乙酰胺 N-(乙氧基乙酰基)去乙酰基硫代秋水仙碱 N-(5,6,7,9-四氢-1,2,3-三甲氧基-10-甲硫基-9-氧代苯并[a]庚搭烯-7-基)氨基甲酸乙酯 N-(4-甲酰基-1,2,3,10-四甲氧基-9-氧代-6,7-二氢-5H-苯并[d]庚搭烯-7-基)乙酰胺 N-(10-二甲基氨基-1,2,3-三甲氧基-9-氧代-6,7-二氢-5H-苯并[d]庚搭烯-7-基)乙酰胺 N-(1,2,3,9-四甲氧基-10-氧代-6,7-二氢-5H-苯并[d]庚搭烯-7-基)乙酰胺 N-(1,2,3,10-四甲氧基-9-氧代-5,6,7,9-四氢苯并[a]庚搭烯-7-基)乙酰胺 9H-三苯并[A,C,E][7]环轮烯-9-酮 8-溴甲基-5-氧代-5H-二苯并[a,d]环庚烯-10-腈